Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: Percutaneous Removal and Margin Ablation for Breast Cancer [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating percutaneous removal and margin ablation as a treatment for breast cancer.
-
CLINICAL_TRIALS research · 2013-07-25Clinical Trial Update: A Prospective Assessment of Loss of Grip Strength by Baseline BMI in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitors and Tamoxifen
The document reports a completed clinical trial update that prospectively assesses how baseline body mass index relates to loss of grip stre…
-
CLINICAL_TRIALS research · 2013-07-25Clinical Trial Update: Transformation Potential of E2 Exposed Breast Cancer Susceptibility Gene Mutation Heterozygous Epithelial Breast Cells
This clinical trial update examines whether exposure to estradiol (E2) can promote transformation in epithelial cells heterozygous for BRCA1…
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace) [Phase 4]
This Phase 4 clinical trial aims to identify biomarkers that predict the effectiveness of adjuvant letrozole in postmenopausal breast cancer…
-
CLINICAL_TRIALS trial_result · 2013-07-24Clinical Trial Update: Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting [Phase 2]
A Phase 2 clinical trial evaluated whether yoga reduces chemotherapy-induced nausea and vomiting in patients with breast cancer, malignant n…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-24Clinical Trial Update: Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating sequential high-dose chemotherapy with autologous stem cell transplantation in chemotherapy-sensitive metastatic br…
-
CLINICAL_TRIALS research · 2013-07-23Clinical Trial Update: Triple Negative Breast Cancer Biomarker Study
A completed biomarker-focused clinical trial for metastatic triple-negative breast cancer sponsored by US Oncology Research.
-
CLINICAL_TRIALS trial_result · 2013-07-19Clinical Trial Update: Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer [Phase 2]
A Phase 2 trial comparing Doxorubicin HCl Liposome Injection with weekly Docetaxel in patients with first-relapse metastatic breast cancer, …
-
CLINICAL_TRIALS trial_result · 2013-07-19Clinical Trial Update: Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer [Phase 3]
Phase 3 trial comparing combination chemotherapy with or without trastuzumab in women with breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-19Clinical Trial Update: Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer [Phase 1, Phase 2]
Clinical trial update about radiation therapy in treating women with stage I or stage II breast cancer in Phase 1/Phase 2. The study status …
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/2 study evaluating the combination of trastuzumab emtansine (T-DM1) with pertuzuma…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer [Phase 2]
Phase 2 trial update evaluating dose-dense Adriamycin with Cytoxan followed by Abraxane or Taxol plus bevacizumab as adjuvant therapy in bre…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer [Phase 4]
Phase 4 trial evaluating epoetin alfa for chemotherapy-related anemia in women with stage I-III breast cancer; the study is completed.
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer [Phase 1]
A Phase 1 study evaluated intravenous interleukin-4 PE38KDEL cytotoxin in patients with recurrent or metastatic breast cancer, renal cell ca…
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: Phase II Dasatinib Study in Advanced Breast Cancer [Phase 2]
This clinical trial update notes the completion of a Phase II study evaluating dasatinib in patients with advanced breast cancer, with resul…
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating albumin-bound paclitaxel (Abraxane) with carboplatin and Herceptin in advanced breast cancer has completed with res…
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: Epidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
AstraZeneca-sponsored epidemiology study in postmenopausal women with estrogen receptor-positive breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain [Phase 2]
A Phase II safety and tolerability trial evaluating adding bevacizumab to single-agent chemotherapy for breast cancer with brain metastases.…
-
CLINICAL_TRIALS research · 2013-07-16Clinical Trial Update: Effects of Electrical Stimulation on Blood Circulation and Sensibility Tactil in Lymphadenectomy [NA]
This entry reports on a clinical trial conducted by the University of Sao Paulo evaluating the effects of electrical stimulation on blood ci…
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Feasibility of a Supportive Education Program for Latina Breast Cancer Survivors [NA]
A feasibility study evaluating a supportive education program for Latina breast cancer survivors was terminated.
-
CLINICAL_TRIALS trial_result · 2013-07-15Clinical Trial Update: Study of APN201 (Liposomal Recombinant Human Cu/Zn-Superoxide Dismutase) for the Prevention of Radiation-induced Dermatitis in Women With Breast Cancer [Phase 1, Phase 2]
Clinical trial update for APN201 (liposomal recombinant human Cu/Zn-superoxide dismutase) evaluating prevention of radiation-induced dermati…
-
FDA approval · 2013-07-11FDA Approved: FEMARA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for FEMARA (letrozole) submitted by Novartis Pharmaceuticals Corporation. The action updates the…
-
CLINICAL_TRIALS research · 2013-07-11Clinical Trial Update: Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated Radiotherapy [Phase 2]
An update on a Phase 2 trial evaluating accelerated partial breast radiotherapy using Mammosite or intensity-modulated radiotherapy for brea…
-
CLINICAL_TRIALS withdrawal · 2013-07-11Clinical Trial Update: Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer [NA]
A clinical trial evaluating biomarkers from fine-needle aspiration in women at increased or normal risk of breast cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Trastuzumab and Capecitabine in Treating Women With Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating the combination of trastuzumab and capecitabine in women with metastatic breast cancer has completed.